Cialis Articles
Lilly's ED drug Cialis meets endpoint in LUTS/BPH study
19 March 2013
Study finds "Big Pharma" fails at self-policing ED drug advertising
18 February 2013
European Commission approves Lilly's Cialis for BPH
31 October 2012
New uses of Cialis, Votubia, Galvus, Eucreas and Eliquis backed by CHMP, but not Qsiva
24 September 2012
Lilly’s Cialis meets endpoints in Ph III study in men with both erectile dysfunction and BPH
13 October 2011
Batch of approvals and positive opinions from EU’s CHMP
26 October 2009
Japan stock market week to June 1, 2009
3 June 2009
Tracleer plus tadalafil boosts 6MWD
28 May 2009
Lilly's 1st-qtr profit jumps 23.6% to $1.31B
29 April 2009
Japan stock market week to April 20, 2009
21 April 2009
Nippon Shinyaku licenses Japanese rights to Lilly
16 April 2009
No eye damage link for Viagra/Cialis; study
15 April 2009
Calistoga appoints Clifford Stocks as CBO
23 March 2009
ED drugmakers accused of price-fixing in Switzerland
16 February 2009
Lilly swings to loss on ImClone acquisition
9 February 2009
Warning on ED drug-drug interactions
19 January 2009
Takeda and Lilly breach ABPI Code of Practice
8 December 2008
Pfizer withdraws OTC Viagra EU application
1 December 2008
Major fake drug hauls in France, seized in transit
1 December 2008
United Therapeutics plunges 33% as oral PAH drug misses Ph III endpoint, filing delay likely
24 November 2008
Lilly swings into loss in 3rd qtr on legal costs
3 November 2008
US FTC closes, freezes assets of vast drug spam e-mail network
27 October 2008
Dong-A's ED drug approved in Russia
1 September 2008
UK Viagra smuggler targeted USA
4 August 2008
Lilly's 2nd-qtr rise hides coming challenges
4 August 2008
Lilly has good 1Q sales but still disappoints
28 April 2008
Sanofi-Aventis to help market Lilly's Cialis in USA
31 March 2008
Lilly's 4th qtr recovers from Zyprexa settlement
4 February 2008
US Congress to re-open drug import debate
28 January 2008
US FDA approves Lilly's once-daily Cialis
14 January 2008
Eli lilly sees 3rd qtr net income climb 6% as sales jump 19% to $4.6B, raises full-year guidance
29 October 2007
Lilly Japan moves into GP market with Cialis
1 October 2007
Spot checks for fake drugs demonstrated
17 September 2007
Lilly's 2nd-qtr 20% sales hike beats estimates
30 July 2007
EC approves Lilly's Cialis
2 July 2007
Lilly completes $2.3B ICOS purchase
12 February 2007
UPDATE: Lilly increases ICOS offer 6% to $2.3B
22 December 2006
Lilly reiterates 2006/07 guidance, disappoints
18 December 2006
Eli Lilly will not cut back in France
20 November 2006
SCP to distribute Dong-A's Zydena in Middle East
6 November 2006
Lilly's 3rd-qtr 2006 profit rises 10% on Zyprexa
30 October 2006
Lilly to buy ICOS for $2.1B, $32 per share
23 October 2006
US counterfeit drug scam used Internet spam
9 October 2006
Biotech stocks in holding pattern for August, says Burrill report
18 September 2006
Lilly swings to 2nd-qtr 2006 EPS of $0.76
31 July 2006
Stock Commentary - New York week toJune 12, 2006
19 June 2006
EU filing for once-daily dosing of Cialis
12 June 2006
ICOS swings to $65M profit in 1st-qtr 2006
15 May 2006
Eli Lilly profit up 6% in 1st-qtr 2006
1 May 2006
Cialis sees good efficacy despite SC injury
17 April 2006
Fake drugs in China, govt wants recognition
3 April 2006
Lilly swings to 4th-qtr 2005 profit
6 February 2006
Stock Commentary - New York week to Jan 23
30 January 2006
Dong-A's ED drug cleared in Korea
5 December 2005
USA
22 August 2005
US FDA posts DSOB meeting summary
15 August 2005
Lilly ICOS slashes loss
1 August 2005
Lilly swings to loss in 2nd qtr on settlement
1 August 2005
US FDA calls for ED drug vision warning
18 July 2005
House votes US federal funding ban on ED drugs
4 July 2005
FDA assesses ED drug link to blindness
6 June 2005
ICOS' 1st-qtr share losses narrow to $0.73
23 May 2005
Eli Lilly reports 84% income rise in 1st qtr
25 April 2005
Tougher pharma patent laws bringing multinationals back to India
7 February 2005
Cialis joins BASS as premier sponsor
31 January 2005
Stock Commentary - New York
13 December 2004
Lilly ICOS celebrates a "promising" first year of Cialis in the USA
13 December 2004
Stock Commentary - New York
1 November 2004
Counterfeit Reductil found in UK
13 September 2004
In August, biotech emerges from doldrums, but uncertainty persists: Burrill review
13 September 2004
Lilly ICOS claims increased market share for Cialis
30 August 2004
ICOS sees net loss widen for 2nd qtr
16 August 2004
Stock Commentary - New York
26 July 2004
Stock Commentary - New York
19 July 2004
Lilly ICOS' Cialis gaining US ED market share
7 June 2004
Bayer/GSK's Levitra takes 3rd place in UK
3 May 2004
Lilly sees sales climb 17% for 1st-qtr 2004
26 April 2004
Thumbs-up for Viagra in ED treatment survey
29 March 2004
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
